Year-over-year earnings per share growth for the last twelve months: Compass Therapeutics (CMPX)
Compass Therapeutics focuses on developing antibodies to combat solid tumors, advancing the drug CTX-009 to capture the biliary tract treatment niche. This quarterly earnings per share growth chart confirms this trend, where 6.50 reflects the metric's baseline. Drug delivery requires costly temperature control, and the absence of sales makes the stock price dependent on test results and patents.
Comprehensive metric breakdowns and analytics for Compass Therapeutics Corp (CMPX)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt and liquidity details:
- earnings and market multiples details:
CMPX - Final Profit|Projected Future Earnings Compass Therapeutics|CMPX - Market Cap to Earnings|Future Price to Earnings Compass Bio|CMPX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Compass Bio|CMPX - Operating profit EBITDA|Earnings per share for the last twelve months Compass Therapeutics|CMPX - Earnings per one share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months compasstherapeutics.com|CMPX - Earnings per share growth rate in current year|Earnings growth forecast for next year Compass Therapeutics
Comprehensive company analysis:Compass Therapeutics, Inc., CMPX
Compass Therapeutics is optimizing profitability through laboratory diversification and the stockpiling of biocomponents for antibody logistics. This price action reflects comparable quarterly EPS growth, which measures the percentage change in net income per share relative to the previous period. This indicator reveals the actual speed of business scaling by filtering out short-term volatility. Analysis of this chart allows for the determination of the asset's development phase, which is critical for assessing the fair value of capital.
Competitors of Compass Therapeutics
IBRX: Quarterly EPS earnings growth|IMCR - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Janux Pharma|Year-over-year net earnings per share growth for the last 12 months Arcus Corp (RCUS)|Year-over-year earnings per share growth for the last twelve months Zymeworks Inc. (ZYME)|Year-over-year net earnings per share growth for the last 12 months tangotx.com TNGX|Iovance Biotherapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Immatics NV IMTX|XNCR - Year-over-year earnings per share growth for the last twelve months|REPL (Replimune Inc.) - Year-over-year earnings per share growth for the last 12 months|Lyell Immunopharma (LYEL) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months innate-pharma.com (IPHA)|Year-over-year net earnings per share growth for the last 12 months PYXS|CGEN - Net earnings per share growth for the trailing year|Year-over-year net earnings per share growth for the last 12 months IOBT (IO Biotech Corp)|Year-over-year earnings per share growth rate for the last twelve months STRO|Quarterly EPS earnings growth INKT (MiNK Therapeutics, Inc.)|Year-over-year earnings per one share growth for the last 12 months HOWL|Immix - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months alxoncology.com|Cue Biopharma (CUE) - Year-over-year earnings per share growth for the last twelve months|PDS Biotechnology Corporation - Year-over-year earnings per one share growth for the last 12 months|SONN (Sonnet BioTherapeutics Holdings, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth MAIABiotech.com|Year-over-year earnings per share growth for the last twelve months Liminatus Pharma LLC (LIMN)|LVTX: Year-over-year net earnings per share trend for the last twelve months|NextCure Corp - Year-over-year net earnings per share growth for the last 12 months|Leap Therapeutics Inc (LPTX) - Earnings per share growth in annualized terms for the last twelve months|Intensity Tx - Quarterly EPS earnings growth|Sensei Biotherapeutics (SNSE) - Year-over-year net earnings per share growth for the last 12 months|Theriva Biologics (TOVX) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Gritstone bio (GRTS)|Year-over-year earnings per share growth for the last twelve months Kineta Bio|Year-over-year net earnings per share growth for the last 12 months NexImmune Corporation (NEXI)|Year-over-year earnings per share growth for the last twelve months Turnstone Biologics (TSBX)|VCNX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth HARP (Harpoon Therapeutics, Inc.)
